FDA launches Drug Safety Newsletter

Share this article:
The FDA has launched Drug Safety Newsletter, a quarterly digest of post-marketing drug safety reviews, important emerging drug safety issues and recently approved drugs for healthcare professionals. The newsletter is part of FDA's response to the Institute of Medicine's 2006 report, The Future of Drug Safety—Promoting and Protecting the Public.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.